Glaxosmithkline Pharmaceuticals Ltd.

BSE: 532540 NSE: Glaxosmithkline Pharmaceuticals ISIN:  INE467B01029 SECTOR: IT Software Company Company’s Website: IPO Date & Price: July 29, 2004 | Rs.

Glaxosmithkline Pharmaceuticals Overview:

Stock Symbol in BSECurrent PriceMarket Cap. (Cr)P/E RatioCurrent EPSStock Symbol in NSE
BSE: 500660₹1,522.00₹25,690.43₹52.60₹28.94NSE:GLAXO
52 Week LowDay OpenDay HighDay LowVolumes52 Week High
How Near from 52Week Low?Today ChangesGlaxosmithkline Pharmaceuticals Ltd.Outstanding Shares [Cr.]Face valueLast Traded TimeCurrent Price Fall From 52W high
4.80%7.1016.94₹1.005/17/2022 15:30:0020.68%

Glaxosmithkline Pharmaceuticals

Its the Indian No-1 multinational information service and consulting Provider company. Glaxosmithkline Pharmaceuticals is the Subsidiary Company of TATA Group and it’s founded in 1968.

Glaxosmithkline Pharmaceuticals Sector Performance and Peer Comparison with Sector Analysis:

Did You Know?

<Space for Feature Image>

  • Glaxosmithkline Pharmaceuticals is the
  • Its Belong to Group.

Balance Sheets & Profit & Loss Account:

YearMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2016Mar 2015Mar 2017Mar 2018Mar 2019Mar 2020
Net Profit508561429562482476337376351445931,200
EPS in Rs.29.9833.0925.333.1728.4328.1219.8822.220.726.295.5120
Dividend Payout %50%60%89%75%88%111%75%113%85%76%727%80%
Profit Grouth Rates10.43%-23.53%31.00%-14.23%-1.24%-10.37%-21.01%4.15%26.78%-79.10%1190.32%
Avearge Profit Grouth Rates-6.55%5.97%0.92%0.49%-4.14%-3.10%-3.10%0.22%-7.71%101.20%

Glaxosmithkline Pharmaceuticals Share Price Forecast Based on Current Growth +5/-5:

Share Price and EPS Forecast Based on Current Average Growth Rates:

Next 5 Years (CG)Next 10 Years (CG)Next 20 Years (CG)

Share Price and EPS Forecast Based on Current Average Growth Rates Plus 5%:

Next 5 Years (CG+5%)Next 10 Years (CG+5%)Next 20 Years (CG+5%)

Share Price and EPS Forecast Based on Current Average Growth Rates Minus 5%:

Next 5 Years (CG-5%)Next 20 Years (CG-5%)Next 10 Years (CG-5%)

Glaxosmithkline Pharmaceuticals Quarterly Result, Date & Street Estimate:

Stock Symbol in NSEShare NameQuarter ResultsYearStreet EstimatesProfitsGrowth
NSE:GLAXOGlaxoSmithKline Pharmaceuticals LimitedQ1 Results2022
N/AGlaxoSmithKline Pharmaceuticals LimitedQ2 Results2022
N/AGlaxoSmithKline Pharmaceuticals LimitedQ3 Results2022
N/AGlaxoSmithKline Pharmaceuticals LimitedQ4 Results2022
N/AGlaxoSmithKline Pharmaceuticals LimitedQ1 Results2021
N/AGlaxoSmithKline Pharmaceuticals LimitedQ2 Results2021
N/AGlaxoSmithKline Pharmaceuticals LimitedQ3 Results2021
N/AGlaxoSmithKline Pharmaceuticals LimitedQ4 Results2021

Fundamental Analysis of Glaxosmithkline Pharmaceuticals :

Glaxosmithkline Pharmaceuticals Share Long Term Investment Price Target:

Long Term Investment TagetsPriceQnt.Ratio
Lot-1₹1,343.1320 [1X]
Lot-2₹1,247.1940 [2X]
Lot-3₹1,151.2580 [4X]
Lot-4₹1,055.31180 [8X]

Glaxosmithkline Pharmaceuticals Fundamentals SWAT Analysis by AMT

 Strengths, Weaknesses, Opportunities, and Threats of Glaxosmithkline Pharmaceuticals


  • Strengths Analysis will coming Soon.


  • Weakness Analysis will coming Soon.


  • Opportunity Analysis will coming Soon.


  • Threats Analysis will coming Soon.

Where we can See Glaxosmithkline Pharmaceuticals in Next 5 Year, 10 Year & 20 Year?

Technical Analysis of Glaxosmithkline Pharmaceuticals :

Glaxosmithkline Pharmaceuticals Share Weekly Swing Trading Price Target:

Demand And Supply ZoneSupport LevelsSupport PriceResistance LevelsResistance Price

Glaxosmithkline Pharmaceuticals Share Today Intraday Price Target:

IntradayTarget Today [Short Selling]IntradayTarget Today [Long Buying]

FAQ on Glaxosmithkline Pharmaceuticals :

Is it Good to Buy Glaxosmithkline Pharmaceuticals Share?

Yes, Glaxosmithkline Pharmaceuticals is India Number-1 IT Software company, with lots business potential in next few year. Its Fundamentally strong Stock we recommend to buy at around 20-25 PE Ration price target. Anyway This company is quite famous for Good Dividends.

Is Glaxosmithkline Pharmaceuticals Debt Free Company?

Glaxosmithkline Pharmaceuticals is a Debt free company. Its can easily survived any down turn for 5-10 Quarter business growth.

Is Glaxosmithkline Pharmaceuticals Overvalued?

Currently Glaxosmithkline Pharmaceuticals is Trading at P/E Ratio which is

Is Glaxosmithkline Pharmaceuticals Better than Infosys?

Both and working as a

Why Glaxosmithkline Pharmaceuticals Share Price is Falling?

Do to Covid-19 pandemic Glaxosmithkline Pharmaceuticals Share drastically fall.

Why Glaxosmithkline Pharmaceuticals Share Price is Going Up?

Is Glaxosmithkline Pharmaceuticals Good for Long Term Investment?

Its depend on when you and at what price you have buy this share, Glaxosmithkline Pharmaceuticals at 20-25 P/E Ration is a excellent buy call for long Term Investment.

Glaxosmithkline Pharmaceuticals ‘s Products/Projects:


IPO, Split, Bonus, Dividend Buyback History:

Glaxosmithkline Pharmaceuticals First IPO was initiate on July 29, 2004. equity shares were put on sale during the IPO with a price band of Rs -Rs per equity share.

[ninja_tables id=”79086″

Company Profile:

CEO NameEmma Walmsley
CFO NameMehernosh Kapadia
CEO SalaryN/A
Company Address
Dr. Annie Besant Road, Mumbai 400030, Maharashtra, India
Contact Number+91-22-24959595
Email Address [email protected]

Declaration: Investing in the Stock market is full of Risky. AllMoneyTips.COM doesn’t give any guarantee or warranted on its investment advice. Do your research before investing in the stock market. Our Forecast and buying selling levels of stocks is based on price action and demand and supply zone. There is no guarantee come with our prediction. Take it as advice only. We are not responsible for your losses on your investments.